445 The relationship between immune-related adverse events (irAEs) and ctDNA status: exploratory analysis from IMvigor010

• Thomas Powles,
• Sanjeev Mariathasan,
• Rajat Mohindra,
• G Scott Chandler,
• Corey Carter,
• Katrin Madjar,
• Bogdana I Balas,
• Laurent Essioux,
• Viraj Degaonkar

Affiliations

Thomas Powles

Barts Cancer Centre, London, UK

Sanjeev Mariathasan

Department of Oncology Biomarker Development, Genentech Inc, South San Francisco, California, USA

Rajat Mohindra

2F.Hoffmann-La Roche Ltd, Basel, Switzerland

G Scott Chandler

6Genentech/Roche, Basel, Switzerland

Corey Carter

1Genentech, Inc., South San Francisco, CA, USA

Katrin Madjar

2F. Hoffmann-La Roche Ltd., Basel, Switzerland

Bogdana I Balas

2F. Hoffmann-La Roche Ltd., Basel, Switzerland

Laurent Essioux

2F. Hoffmann-La Roche Ltd., Basel, Switzerland

Viraj Degaonkar

1Genentech, Inc., South San Francisco, CA, USA